Stock Events

Stock Events

ClearPoint Neuro 

$13.96
275
-$0.09-0.64% Friday 20:00
+$0.04+0.29%Friday 23:33After hours

Statistics

Day High
14.09
Day Low
13.78
52W High
30.1
52W Low
8.27
Volume
384,792
Avg. Volume
722,188
Mkt Cap
425.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.38
-0.31
-0.23
-0.16
Expected EPS
-0.315
Actual EPS
N/A

Financials

-69.08%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
36.97MRevenue
-25.54MNet Income

Analyst Ratings

30.00Average Price Target
The highest estimate is 30.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLPT. It's not an investment recommendation.
Rocket Lab
84
RKLB
NVIDIA
81
NVDA
Alphabet
74
GOOGL
Amazon
73
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical is a competitor because it specializes in robotic-assisted surgeries, a field where ClearPoint Neuro's precision navigation and therapy delivery systems could be applied.
Medtronic
MDT
Mkt Cap116.77B
Medtronic competes in the neurosurgery space with its own range of surgical navigation systems and robotics, directly competing with ClearPoint Neuro's offerings.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew operates in the advanced surgical and robotics field, overlapping with ClearPoint Neuro's market in neurosurgery and precision therapeutic applications.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the area of surgical solutions, including technologies that could be used in neurosurgical procedures, a direct competition to ClearPoint Neuro.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation offers products in neuromodulation, competing with ClearPoint Neuro in the broader neurosurgical equipment and technology market.
Globus Medical
GMED
Mkt Cap11.14B
Globus Medical, Inc. competes with its advancements in musculoskeletal solutions and minimally invasive surgical technologies, which can be applied to neurosurgery, overlapping with ClearPoint Neuro's market.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is a competitor due to its neurotechnology and spine division, offering products that compete with ClearPoint Neuro's neurosurgical navigation and therapy delivery systems.
NovoCure
NVCR
Mkt Cap2.08B
NovoCure operates with its Tumor Treating Fields technology, a novel therapy that competes with ClearPoint Neuro's targeted therapeutic delivery systems for brain conditions.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, including therapies for neurological disorders, potentially competing with ClearPoint Neuro's therapeutic applications.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is involved in the development of treatments for neurological conditions, which could compete with ClearPoint Neuro's focus on delivering therapies directly to the brain.

About

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Show more...
CEO
Joseph Michael Burnett
Employees
172
Country
United States
ISIN
US18507C1036

Listings

BOATS
BOATS
CLPT.BOATS
XNAS
US
CLPT

0 Comments

Share your thoughts

FAQ

What is ClearPoint Neuro stock price today?▼
The current price of CLPT is $13.96 USD — it has decreased by -0.64% in the past 24 hours. Watch ClearPoint Neuro stock price performance more closely on the chart.
What is ClearPoint Neuro stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ClearPoint Neuro stocks are traded under the ticker CLPT.
Is ClearPoint Neuro stock price growing?▼
CLPT stock has fallen by -10.23% compared to the previous week, the month change is a +6.08% rise, over the last year ClearPoint Neuro has showed a +26.33% increase.
What is ClearPoint Neuro market cap?▼
Today ClearPoint Neuro has the market capitalization of 425.84M
When is the next ClearPoint Neuro earnings date?▼
ClearPoint Neuro is going to release the next earnings report on November 05, 2026.
What were ClearPoint Neuro earnings last quarter?▼
CLPT earnings for the last quarter are -0.38 USD per share, whereas the estimation was -0.29 USD resulting in a -32.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ClearPoint Neuro revenue for the last year?▼
ClearPoint Neuro revenue for the last year amounts to 36.97M USD.
What is ClearPoint Neuro net income for the last year?▼
CLPT net income for the last year is -25.54M USD.
How many employees does ClearPoint Neuro have?▼
As of September 05, 2026, the company has 172 employees.
In which sector is ClearPoint Neuro located?▼
ClearPoint Neuro operates in the Health & Wellness sector.
When did ClearPoint Neuro complete a stock split?▼
The last stock split for ClearPoint Neuro was on July 27, 2016 with a ratio of 1:40.
Where is ClearPoint Neuro headquartered?▼
ClearPoint Neuro is headquartered in SOLANA BEACH, United States.